BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11838322)

  • 1. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase inhibitors: recent developments.
    Sarges R; Oates PJ
    Prog Drug Res; 1993; 40():99-161. PubMed ID: 8356214
    [No Abstract]   [Full Text] [Related]  

  • 3. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 4. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract]   [Full Text] [Related]  

  • 5. Aldose reductase inhibitors and diabetic complications.
    Tomlinson DR; Willars GB; Carrington AL
    Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
    Tomlinson DR; Stevens EJ; Diemel LT
    Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
    Cattalini M; Lerario AC
    Rev Assoc Med Bras (1992); 1996; 42(2):109-14. PubMed ID: 9110460
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S; Buyukbingol E
    Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Kador PF; Kinoshita JH; Sharpless NE
    J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of diabetic complications.
    Altan VM
    Curr Med Chem; 2003 Aug; 10(15):1317-27. PubMed ID: 12871132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
    Boel E; Selmer J; Flodgaard HJ; Jensen T
    J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM; Caro-Sampara F; Blicklé JF
    Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004?
    Gabbay KH
    Curr Diab Rep; 2004 Dec; 4(6):405-8. PubMed ID: 15539002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase: a window to the treatment of diabetic complications?
    Crabbe MJ; Goode D
    Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches.
    Costantino L; Rastelli G; Vianello P; Cignarella G; Barlocco D
    Med Res Rev; 1999 Jan; 19(1):3-23. PubMed ID: 9918192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches for treatment in diabetes: aldose reductase inhibitors.
    Hotta N
    Biomed Pharmacother; 1995; 49(5):232-43. PubMed ID: 7579002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.